Effectiveness and safety of pamidronate treatment in nonambulatory children with low bone mineral density

Purpose Nonambulatory pediatric patients may have low bone mineral density (BMD) and increased risk of pathologic fractures. Though bisphosphonate therapy is the mainstream medical intervention in these children, clinical data regarding this treatment are limited. Therefore, this study aimed to eval...

Full description

Bibliographic Details
Published in:	Annals of Pediatric Endocrinology & Metabolism
Main Authors:	Myeongseob Lee, Ahreum Kwon, Kyungchul Song, Hae In Lee, Han Saem Choi, Junghwan Suh, Hyun Wook Chae, Ho-Seong Kim
Format:	Article
Language:	English
Published:	Korean Society of Pediatric Endocrinology 2024-02-01
Subjects:	osteoporosis bone density diphosphonates pamidronate immobilization
Online Access:	http://e-apem.org/upload/pdf/apem-2346028-014.pdf

Similar Items

Therapy with pamidronate in children with osteogenesis imperfecta
by: Marginean O, et al.
Published: (2017-08-01)

Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents
by: Ji-Hee Yoon, et al.
Published: (2021-06-01)

Use of pamidronate for osteoporosis treatment in public health care in Brazil
by: Leila Bianchet Zanatta, et al.

Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density
by: Se Won Lim, et al.
Published: (2016-03-01)

Intravenous pamidronate for refractory rheumatoid arthritis
by: Mansour Salesi, et al.
Published: (2012-01-01)

Effectiveness of Pamidronate Infusion in the Treatment of Charcot Arthropathy
by: Bajuri MY, et al.
Published: (2024-03-01)

Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats
by: F.A. Pereira, et al.
Published: (2012-12-01)

Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats
by: F.A. Pereira, et al.
Published: (2012-12-01)

Evaluation of Two Different Pamidronate Treatment Protocols in Children with Osteogenesis Imperfecta
by: Neslihan Onenli Mungan, et al.
Published: (2014-06-01)

Comparison of Calcitonin and Pamidronate Treatments in Children with Osteogenesis Imperfecta
by: Neslihan Onenli Mungan, et al.
Published: (2013-08-01)

Pamidronate-induced irreversible symptomatic hypocalcemia in a dog with hypercalcemia after glucocorticoid withdrawal: a case report
by: Ye-In Oh, et al.
Published: (2024-05-01)

Adherence of bisphosphonate and decreased risk of clinical vertebral fracture in osteoporotic patients: A propensity score matching analysis
by: Seihee Kim, et al.
Published: (2022-09-01)

Intravenous Pamidronate Therapy in Taiwanese Patients with Osteogenesis Imperfecta
by: Hsiang-Yu Lin, et al.
Published: (2008-10-01)

Diagnosis and Management of Osteoporosis in Children and Adolescents
by: Hye Young Jin, et al.
Published: (2023-10-01)

Assessment of the Effect of Intravenous Pamidronate in the Treatment of Legg-Calve-Perthes Disease in Children
by: Niloofar Shashaani, et al.
Published: (2024-07-01)

Re-evaluated data of dissociation constants of alendronic, pamidronic and olpadronic acids
by: Boichenko Alexander, et al.
Published: (2009-03-01)

Use of disodium pamidronate bisphosphonate in patients with bone metastases of lung cancer
by: Ranković Boško, et al.
Published: (2002-01-01)

Safety and Efficacy of Pamidronate in Neonatal Hypercalcemia Caused by Subcutaneous Fat Necrosis: A Case Report
by: Stefano Martinelli, et al.
Published: (2022-04-01)

Efficacy of pamidronate in children with chronic non-bacterial osteitis using whole body MRI as a marker of disease activity
by: C. S. Bhat, et al.
Published: (2019-07-01)

Evaluation of the efficacy and tolerance of pamidronate in complex regional pain syndrom type 1
by: Marie Doussiere, et al.
Published: (2025-07-01)

Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome
by: Funda Baştuğ, et al.
Published: (2018-04-01)

The Effects of Polyphenol, Tannic Acid, or Tannic Acid in Combination with Pamidronate on Human Osteoblast Cell Line Metabolism
by: Hermizi Hapidin, et al.
Published: (2022-01-01)

Important hypercalcemia due to subcutaneous fat necrosis treated with pamidronate in an infant with severe hypoxic-ischemic encephalopathy
by: Pasqua Anna Quitadamo, et al.
Published: (2016-08-01)

Cyclic pamidronate treatment for osteogenesis imperfecta: Report from a Brazilian reference center
by: Bruna Pinheiro, et al.
Published: (2019-04-01)

Molecular Mechanisms Responsible for the Rescue Effects of Pamidronate on Muscle Atrophy in Pediatric Burn Patients
by: Fabrizio Pin, et al.
Published: (2019-08-01)

Insulin Requirement and Complications Associated With Serum C-Peptide Decline in Patients With Type 1 Diabetes Mellitus During 15 Years After Diagnosis
by: Junghwan Suh, et al.
Published: (2022-04-01)

Neonatal Hypercalcemia Secondary to Subcutaneous Fat Necrosis Successfully Treated with Pamidronate: A Case Series and Literature Review
by: Veronica Mugarab Samedi, et al.
Published: (2014-11-01)

Extensive protein expression changes induced by pamidronate in RAW 264.7 cells as determined by IP-HPLC
by: Sang Shin Lee, et al.
Published: (2020-05-01)

Osteodestruction markers and quality of life parameters at pomegara (pamidronate) treatment in multiple myeloma patients with lytic bone lesions
by: V. V. Lunin, et al.
Published: (2022-11-01)

A Systematic Review and Meta Analysis of Non-Randomized Interventional Studies on the Pamidronate Treatment Efficacy for Patients with Bone Fibrous Dysplasia
by: Nicolas Daniel Widjanarko, et al.
Published: (2023-12-01)

Combination treatment of bisphosphonate (pamidronate) and Quercus infectoria semi- purified fraction promotes proliferation and differentiation of osteoblast cell via expression of Osterix and Runx2 marker
by: Abdullah Amira Raudhah, et al.
Published: (2018-01-01)

Pamidronate decreases bilirubin-impaired cell death and improves dentinogenic dysfunction of stem cells from human deciduous teeth
by: Haruyoshi Yamaza, et al.
Published: (2018-11-01)

Efficacy of combination therapy of vitamin D and bisphosphonates in the treatment of postmenopausal osteoporosis: a systematic review and meta-analysis
by: Yuangui Yang, et al.
Published: (2024-11-01)

Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
by: Lianghai Jiang, et al.
Published: (2022-11-01)

Effect of catch-up sleep on obesity in Korean adolescents: a nationwide cross-sectional study
by: Youngha Choi, et al.
Published: (2023-07-01)

Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer
by: J.F. Hilton, et al.
Published: (2018-03-01)

Comparison of the effect of gonadotropin-releasing hormone agonist dosage in girls with central precocious puberty
by: Shinyoung Jang, et al.
Published: (2023-02-01)

Maturity-onset diabetes of the young due to gene mutation
by: Hae In Lee, et al.
Published: (2023-12-01)

Trends in Prediabetes and Non-Alcoholic Fatty Liver Disease Associated with Abdominal Obesity among Korean Children and Adolescents: Based on the Korea National Health and Nutrition Examination Survey between 2009 and 2018
by: Kyungchul Song, et al.
Published: (2022-03-01)

Preparation, Optimisation, and In Vitro Evaluation of [<sup>18</sup>F]AlF-NOTA-Pamidronic Acid for Bone Imaging PET
by: Hishar Hassan, et al.
Published: (2022-11-01)